Health Care
Medtronic stock gains on strong Q2 results, guidance
Aided by the impressive performance of its key business segments, medical device maker Medtronic (MDT) reported a 6% increase in…
Tesaro shares spike on buyout news, trading halted
Shares of Tesaro (TSRO), an oncology-focused biopharma company, skyrocketed after the news that it has been working with advisors for a…
Arena Pharmaceuticals soars on the $1.2 billion deal with United Therapeutics
Arena Pharmaceuticals (ARNA) inked a deal with United Therapeutics (UTHR) to sell and develop its Phase 3 investigational drug candidate…
Amarin turns positive after Citi upgrade and CEO’s clarification on REDUCE-IT study
Amarin Corporation (AMRN) shares turned to green Wednesday after they were battered out in the last two days following the…
Allergan, Mylan and other generics beam as Pfizer loses patent war in the UK
It was good news for generic drug firms such as Allergan (AGN) and Mylan (MYL), as pharma giant Pfizer (PFE)…
Cronos reports loss in 3Q despite strong revenue growth
Cannabis producer Cronos Group (CRON) revenues jumped 186% to CAD3.76 million for the third quarter 2018, aided by strong sales…
Earnings preview: Tilray stock might see big fluctuations post Q3 results
It can be safely said that cannabis is this year’s bitcoin – be it the debates surrounding its regulation or…
AstraZeneca Q3 profit dips 37% but beats estimates
AstraZeneca Plc (AZN) reported a 37% dip in earnings for the third quarter due to lower revenue, a decline in…
Cardinal Health posts better-than-expected Q1 earnings
Cardinal Health Inc. (CAH) reported a 408% jump in earnings for the first quarter helped by a gain on disposal…
The ‘midterm’ shot sends cannabis stocks to a new high
The midterm election has brought cheer to companies doing marijuana-related businesses in the US, despite the uncertainties surrounding regulation of…